Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare bill: diabetes, CV (cardiovascular) screening provisions delight industry

This article was originally published in Clinica

Executive Summary

Prescription drug coverage is not the only new benefit of note in the historic Medicare bill that cleared the US Congress on November 25. This bill, which President Bush is expected to sign into law in the next few days, also covers two new preventive services of note for the diagnostics industry -screening tests for diabetes and cardiovascular disease.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT065397

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel